Penserra Capital Management LLC Intellia Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023
SELL
$31.62 - $45.78 $3,320 - $4,806
-105 Reduced 1.58%
6,528 $206,000
Q2 2023

Aug 11, 2023
BUY
$34.58 - $46.03 $9,440 - $12,566
273 Added 4.29%
6,633 $270,000
Q1 2023

Apr 24, 2023
BUY
$33.3 - $44.82 $24,641 - $33,166
740 Added 13.17%
6,360 $237,000
Q4 2022

Feb 13, 2023
SELL
$33.21 - $62.69 $104,677 - $197,598
-3,152 Reduced 35.93%
5,620 $196,000
Q3 2022

Nov 14, 2022
BUY
$53.92 - $71.7 $358,891 - $477,235
6,656 Added 314.56%
8,772 $490,000
Q2 2022

Aug 15, 2022
BUY
$38.49 - $76.21 $29,560 - $58,529
768 Added 56.97%
2,116 $109,000
Q1 2022

May 13, 2022
BUY
$58.27 - $118.99 $78,547 - $160,398
1,348 New
1,348 $97,000
Q4 2021

Feb 15, 2022
SELL
$100.76 - $138.36 $169,276 - $232,444
-1,680 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$132.37 - $176.78 $17,208 - $22,981
130 Added 8.39%
1,680 $225,000
Q2 2021

Aug 12, 2021
BUY
$60.88 - $161.91 $1,217 - $3,238
20 Added 1.31%
1,550 $250,000
Q1 2021

May 13, 2021
BUY
$46.59 - $83.68 $7,687 - $13,807
165 Added 12.09%
1,530 $122,000
Q4 2020

Feb 12, 2021
BUY
$18.83 - $63.53 $16,212 - $54,699
861 Added 170.83%
1,365 $74,000
Q3 2020

Nov 13, 2020
BUY
$17.47 - $24.93 $8,804 - $12,564
504 New
504 $10,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email